First clinical case of KPC-3-producing in Europe

Publikation

First clinical case of KPC-3-producing in Europe

Wissenschaftlicher Artikel/Review - 23.02.2019

Seiffert S N, Wüthrich D, Gerth Y, Egli A, Kohler Philipp, Nolte O

Zitation

Seiffert S, Wüthrich D, Gerth Y, Egli A, Kohler P, Nolte O. First clinical case of KPC-3-producing in Europe. New Microbes New Infect 2019; 29:100516.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

New Microbes New Infect 2019; 29

Veröffentlichungsdatum

23.02.2019

ISSN (Druck)

2052-2975

Seiten

100516

Kurzbeschreibung/Zielsetzung

is a newly emerging human pathogen. We describe a case of bloodstream infection in an immunocompromised patient. The pathogen was repeatedly isolated from blood and one rectal swab, and was identified using routine standard procedures. Further investigations revealed that the was multidrug resistant, carrying a plasmid harbouring a carbapenemase (KPC)-3 carbapenemase gene. This plasmid has been frequently encountered in isolates in Europe but has never been described in